By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BD Diagnostics, a division of Becton Dickinson, announced on Monday that it has filed an application with the US Food and Drug Administration for 510(k) clearance of the first fully automated molecular tests for herpes simplex virus types 1 and 2.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.